Goldman Sachs downgraded Covance (NYSE: CVD) from Buy to Neutral citing limited upside to their $101 price target.

Analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE